~~<i id='5545CC2AD5'><strike id='5545CC2AD5'><tt id='5545CC2AD5'><pre id='5545CC2AD5'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

author：entertainment 2025-09-29 19:58:49 - browse：78361

AP/Richard Drew

Johnson & Johnson said Monday that it would purchase Ambrx Biopharma for nearly $2 billion, picking up a company specializing in targeted chemotherapy treatments — one of the hottest areas of cancer drug development.

The deal, disclosed as the biopharma field marked the first day of the annual J.P. Morgan Healthcare Conference, extends a recent spate of pharma acquisitions, contributing to hopes that 2024 could be a better year for the industry.

Under the agreement, J&J will pay $28 per share in cash for Ambrx, roughly a 100% premium to the latter’s recent trading price.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： HPV cancer vaccine study demonstrates efficacy

hotspot

leisure time

Wikipedia

hotspot

RepublicanpresidentialcandidateformerU.N.AmbassadorNikkiHaleyspeaksasformerNewJerseyGov.ChrisChristi

WSS

Supreme Court strikes down use of affirmative action

Senate panel clears PBM, hopsital reforms

STAT Executive Editor Rick Berke on STAT's 8th birthday

White House calls on federal agencies to crack down on AI abuses

10 million people disenrolled from Medicaid over past six months

As demand for Covid shots wanes, Moderna seeks its next success

focus

focus

hotspot

The high cost of giving birth even with insurance

Tori Bowie and the unacceptable rates of Black maternal death

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Trump demands the U.S. pay no more for drugs than other countries … again

Tori Bowie and the unacceptable rates of Black maternal death

Continuity nursing helped my family in our darkest PICU moments

Activists slam private health insurers over coverage restrictions

Continuity nursing helped my family in our darkest PICU moments

Trump demands the U.S. pay no more for drugs than other countries … again

Medical records are filled with copy

leisure time

Biotech incubator Curie.Bio graduates its first startup

FDA approves potent Eli Lilly obesity drug, Zepbound

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

10 million people disenrolled from Medicaid over past six months

Just how powerful is the placebo effect?

ChatGPT in medicine: STAT answers readers' burning questions

Wikipedia

Wikipedia

hotspot

hotspot